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DO2 = systemic oxygen delivery; EGDT = early goal-directed therapy; NO = nitric oxide; PO2 = partial oxygen tension; ScvO2 = central venous
oxygen saturation.
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In his review paper published in the present issue of Critical
Care, Stephan Jakob [1] deals with the difficult and broad
topic of splanchnic ischaemia in critical care. The
presentation is exhaustive, including the still controversial
issue of inadequate gastrointestinal flow in septic states. As
mentioned in that review, several lines of evidence support
the notion that cellular energetics are deranged in sepsis, in
terms not only of inadequate tissue perfusion but also of
impaired mitochondrial respiration and/or coupling (i.e. organ
dysfunction in sepsis may occur as a result of ‘cytopathic
hypoxia’) [2]. If this is correct then the therapeutic
implications might be enormous. It would imply that efforts to
improve outcome in septic patients by monitoring and
manipulating cardiac output, systemic oxygen delivery (DO2)
and regional blood flow are doomed to failure, and that the
focus should rather be on developing pharmacological
strategies to restore normal mitochondrial function and
cellular energetics. This is largely speculative, however, and
the controversy remains regarding whether there is a deficit
in regional DO2 or whether the deficit resides in the inability
of tissue cells to utilize available oxygen adequately.
A deficiency in the ability of tissues to extract oxygen is a
prominent feature of the pathology of sepsis, and this is
especially true at the level of the gut [3]. This deficiency
manifests as a condition in which, despite apparent
correction of global variables of DO2, signs of regional
dysoxia are present (e.g. elevated lactate levels and
enhanced gastric carbon dioxide level – a surrogate marker
for decreased perfusion that is determined tonometrically).
Several investigators have reported that tissue oxygenation is
impaired in experimental models of sepsis. For example, we
investigated the effects of acute endotoxaemia on tissue
partial oxygen tension (PO2) [4]. We took sequential
measurements in a single group of dogs at baseline during a
1-hour infusion of lipopolysaccharide, and then during a
2-hour infusion of dextran solution. Infusion of
lipopolysaccharide resulted in a marked decrease in systemic
DO2, but this parameter was normalized by resuscitating the
animals with a colloid solution. In contrast, the distribution of
intestinal mucosal PO2 remained low despite a marked
increase in mesenteric DO2. Those findings were reproduced
by Hasibeder and coworkers [5] and Tugtekin and coworkers
[6], and the development of tissue hypoxia following injection
of lipopolysaccharide was attributed by those authors to
impaired microvascular control of nutritive flow.
Temmersfeld-Wollbrück and coworkers [7] employed
microlightguide reflectance spectrophotometry for direct
assessment of the microvascular oxyhaemoglobin and its
Commentary
Gut oxygenation in sepsis: still a matter of controversy?
Benoit Vallet
Professor, Department of Anesthesiology and Intensive Care Medicine, University Hospital of Lille, Lille, France
Correspondence: Benoit Vallet, bvallet@chru-lille.fr
Published online: 31 May 2002 Critical Care 2002, 6:282-283
This article is online at http://ccforum.com/content/6/4/282
© 2002 BioMed Central Ltd (Print ISSN 1364-8535; Online ISSN 1466-609X)
Abstract
Part of Stephan Jakob’s exhaustive review paper in the present issue of Critical Care deals with the
notion that intestinal cellular energetics are deranged in sepsis, in terms not only of inadequate tissue
perfusion but also of impaired mitochondrial respiration and/or coupling (i.e. organ dysfunction in
sepsis may occur as a result of ‘cytopathic hypoxia’). This suggests that efforts to improve outcome in
septic patients by manipulating systemic oxygen delivery and regional blood flow are doomed to failure.
That suggestion remains largely speculative, and experimental and clinical results presented here
consistently demonstrate that there is still a place for treatment of abnormal perfusion in the context of
early severe sepsis and septic shock.
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partial distribution in the mucosa of the upper gastrointestinal
tract, and noted profound differences between healthy
control individuals and patients in septic shock. The latter
group was characterized by overall lowered levels of mucosal
oxygenation, concomitant with apparent heterogeneity of
regional oxyhaemoglobin, and the appearance of small
descrete areas of tissue that were severely hypoxic. To our
knowledge, that important study was the first to reproduce
findings in humans that had been observed in animal models,
indicating that during septic shock abnormal microcirculatory
oxygenation occurs in the gastrointestinal tract, despite more
than adequate systemic oxygen derived parameters.
Interestingly, the mucosal to arterial carbon dioxide gap was
increased when mucosal oxyhaemoglobin was decreased.
In contrast to the findings described above, a number of
studies suggest that tissue PO2 values are normal or even
elevated in endotoxaemia or sepsis. For example, Hotchkiss
and coworkers [8] estimated tissue PO2 values in a number
of organs in rats rendered septic by caecal ligation and
perforation. They did not find evidence of tissue hypoxia in
skeletal muscle, cardiac muscle, liver and kidney in septic
rats. VanderMeer and coworkers [9] investigated the effects
of endotoxaemia on intestinal mucosal PO2 in pigs, and did
not identify a decrease in mucosal PO2. Further results from
the same group suggest that sepsis might be associated
with ‘cytopathic hypoxia’, a situation in which impaired
production of ATP exists despite adequate availability of
oxygen in the vicinity of mitochondria within cells. This,
according to those authors’ main hypothesis, followed sepsis
induced nitric oxide (NO) over-production, resulting in lower
levels of oxidative phosphorylation [10].
In an in vitro model of intestinal epithelium [11], incubation
with the NO donors sodium nitroprusside, S-nitroso-N-
acetylpenicillamine, or 1% NO gas reduced ATP levels and
reversibly increased the permeability of intestinal epithelium.
Data regarding the effects of sepsis on tissue levels of
adenine nucleotides (i.e. ATP and ADP) are plentiful but,
largely because of conflicting findings, they are difficult to
interpret [12,13]. One crucial issue has recently been
addressed [14]. In an in situ isolated flow-controlled gut
loop, it was observed that epithelial injury (as assessed by
nuclear chromatin condensation) and mitochondrial swelling
occurred 2 hours before any increase in NO production (as
assessed by nitrotyrosine and inducible NO synthase
immunoprevalence), suggesting that lipopolysaccharide-
induced ileal injury and NO dysregulation were clearly
dissociated in that preparation, with injury preceding nitric
oxide (NO) overproduction.
It was recently confirmed in a clinical trial [15] that impaired
tissue perfusion plays an important role in the development of
multiple organ failure and death during severe sepsis. The
purpose of that study was to evaluate the efficacy of early
goal-directed therapy (EGDT) before admission to the
intensive care unit; EGDT involved adjustments to cardiac
preload, afterload and contractility in order to balance DO2
with oxygen demand. The evaluation was conducted by
monitoring continuous central venous oxygen saturation
(ScvO2; targeting a level >70%). Interestingly, ScvO2 was
lower than a mean value of 50% in patients who arrived at the
emergency department with severe sepsis or septic shock;
this serves as a reminder that, before fluid loading is started,
severe sepsis and septic shock are associated with severely
depressed haemodynamics (as has been demonstrated in
lipopolysaccharide animal models). The patients were
randomly assigned to receive either 6 hours of EGDT
(n = 130) or standard therapy (which differed only in the fact
that ScvO2-based therapy was not used; n = 133) before
admission to the intensive care unit. There were no significant
differences between the groups with respect to baseline
characteristics. During the interval from 7 to 72 hours, the
patients assigned to EGDT had a significantly higher mean
ScvO2, a lower lactate concentration, a lower base deficit and
a higher pH than did the patients assigned to standard
therapy (P < 0.02 or P = 0.02 for all comparisons). In-hospital
mortality was 30.5% in the group assigned to EDGT, as
compared with 46.5% in the group assigned to standard
therapy (P = 0.009).
These experimental and clinical results consistently
demonstrate that there is a place for treatment of abnormal
perfusion in the context of early severe sepsis and septic
shock. They do not exclude, however, that altered oxygen
utilization can follow at a later stage. Whether EGDT acts by
improving gastrointestinal perfusion specifically remains
unknown, but success with this strategy suggests that
treating altered tissue perfusion remains an appropriate
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